Hello and welcome to the Perrigo First Quarter 2021 Financial Results Conference Call. [Operator Instructions]
I would now like to turn the conference over to Bradley Joseph. Mr. Joseph, please go ahead.
Bradley Joseph
Vice President, Global Investor Relations and Corporate Communications
Thank you and good morning, everybody, and welcome to Perrigo s first quarter fiscal 2021 earnings conference call. I hope you all had a chance to review the press release we issued earlier this morning. A copy of the earnings release and presentation for today s discussion are available within the Investors section of the perrigo.com website. Joining today s call are President and CEO, Murray Kessler; and CFO, Ray Silcock.
Operator
Greetings, and welcome to the Collegium Pharmaceutical First Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Alex Dasalla. Please go ahead.
Alex Dasalla
Head of Investor Relations
Welcome to Collegium Pharmaceuticals first quarter 2021 earnings conference call. This is Alex Dasalla, Head of Investor Relations for Collegium. I am joined today by Joe Ciaffoni, our Chief Executive Officer; Paul Brannelly, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.
Before we begin today s call, we want to remind participants that none of the information presented today is intended to be promotional and that any forward-looking statements made today are made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. You are cautioned that such forward-looking statements involve risks and uncertainties, including and with
Greetings. Welcome to BioDelivery Sciences First Quarter 2021 Earnings Call. [Operator Instructions]
I would now like to turn the conference over to Terry Coelho, Executive Vice President and Chief Financial Officer. Thank you. You may begin.
Terry Coelho
Executive Vice President and Chief Financial Officer
Thank you and good morning, everyone. Welcome to our first quarter 2021 earnings conference call. Leading the call today is Jeff Bailey, Chief Executive Officer. We are joined by Scott Plesha, President and Chief Commercial Officer. Following our prepared remarks, we will conduct a question-and-answer session.
Earlier today, BioDelivery Sciences issued a press release announcing its financial results for the first quarter of 2021. A copy of the release can be found on the Investor Relations page of the Company s website. Before we begin, I would like to remind everyone that certain statements may be made during this call which may contain forward-looking statements. Such
Operator
Hello, and welcome to the Amneal First Quarter 2021 Conference Call. [Operator Instructions] Please note today s event is being recorded.
I would now like to turn the call over to Amneal s Head of Investor Relations, Tony DiMeo.
Anthony DiMeo
Senior Director, Investor Relations
Good morning, and thank you for joining us for Amneal s first quarter 2021 earnings call. Earlier this morning, we issued a press release reporting our financial results. The press release as well as the slides that will be presented on this call are available on our website at amneal.com. We re conducting a live webcast of this call, a replay of which will also be available on our website after its conclusion.